{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T16:29:57Z","timestamp":1726417797731},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.arcped.2011.11.021","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T15:54:33Z","timestamp":1326210873000},"page":"165-172","source":"Crossref","is-referenced-by-count":1,"title":["Contribution de la Soci\u00e9t\u00e9 francophone de recherche en p\u00e9diatrie\u00a0: les essais randomis\u00e9s d\u2019interruption du traitement apr\u00e8s enrichissement de population"],"prefix":"10.1016","volume":"19","author":[{"given":"E.","family":"Merlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nourrissat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2011.11.021_bib0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0300-483X(03)00249-X","article-title":"The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children","volume":"192","author":"Johnson","year":"2003","journal-title":"Toxicology"},{"issue":"suppl. 1","key":"10.1016\/j.arcped.2011.11.021_bib0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00228-011-0990-y","article-title":"Innovative study design for paediatric clinical trials","volume":"67","author":"Baiardi","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.arcped.2011.11.021_bib0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pain.2008.01.014","article-title":"Enriched enrolment with randomised withdrawal (EERW): time for a new look at clinical trial design in chronic pain","volume":"135","author":"McQuay","year":"2008","journal-title":"Pain"},{"issue":"suppl. 1","key":"10.1016\/j.arcped.2011.11.021_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0929-693X(03)90359-9","article-title":"Particularit\u00e9s m\u00e9thodologiques et de strat\u00e9gie de d\u00e9veloppement des m\u00e9dicaments chez l\u2019enfant","volume":"10","author":"Pons","year":"2003","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2011.11.021_bib0025","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/clpt.2010.233","article-title":"Enrichment of clinical study populations","volume":"88","author":"Temple","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.arcped.2011.11.021_bib0030","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/AJP.0b013e3181b12dec","article-title":"Enriched enrollment randomized withdrawal trial designs of analgesics: focus on methodology","volume":"25","author":"Katz","year":"2009","journal-title":"Clin J Pain"},{"key":"10.1016\/j.arcped.2011.11.021_bib0035","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.pain.2010.10.050","article-title":"Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain","volume":"152","author":"Hewitt","year":"2011","journal-title":"Pain"},{"issue":"Suppl. 4","key":"10.1016\/j.arcped.2011.11.021_bib0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1212\/WNL.65.12_suppl_4.S32","article-title":"Methodological issues in clinical trials of opioids for chronic pain","volume":"65","author":"Katz","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.arcped.2011.11.021_bib0045","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group","volume":"356","author":"Chiron","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2011.11.021_bib0050","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1164\/rccm.200511-1808OC","article-title":"Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis","volume":"173","author":"Balfour-Lynn","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arcped.2011.11.021_bib0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pain.2009.10.029","article-title":"Two-stage enriched enrolment pain trials: a brief review of designs and opportunities for broader application","volume":"148","author":"Quessy","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.arcped.2011.11.021_bib0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1751-7176.2011.00432.x","article-title":"Effectiveness and safety of valsartan in children aged 6\u00a0to 16\u00a0years with hypertension","volume":"13","author":"Wells","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.arcped.2011.11.021_bib0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2011.11.021_bib0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0920-1211(96)00028-9","article-title":"Vigabatrin withdrawal randomized study in children","volume":"25","author":"Chiron","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.arcped.2011.11.021_bib0075","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2011.11.021_bib0080","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/08830738060210062101","article-title":"Stiripentol in childhood partial epilepsy: randomized placebo-controlled trial with enrichment and withdrawal design","volume":"21","author":"Chiron","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.arcped.2011.11.021_bib0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0304-3959(94)00121-T","article-title":"Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage \u2018enriched enrollment\u2019 design","volume":"60","author":"Byas-Smith","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.arcped.2011.11.021_bib0090","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1526-4637.2011.01100.x","article-title":"Long-term safety of Remoxy(R) (extended-release oxycodone) in patients with moderate to severe chronic osteoarthritis or low back pain","volume":"12","author":"Friedmann","year":"2011","journal-title":"Pain Med"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X11005306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X11005306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T06:00:12Z","timestamp":1543298412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X11005306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0929693X11005306"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2011.11.021","relation":{},"ISSN":["0929-693X"],"issn-type":[{"type":"print","value":"0929-693X"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}